Yale Research Highlights Unmet Needs for Patients With Melanoma Who Progress or Relapse After Immunotherapy Treatment

Source: Yale School Of Medicine , August 2024

A retrospective cohort study by Yale Cancer Center researchers of nearly 200 patients with melanoma who died after receiving treatment with immunotherapy highlights a need to improve outcomes for patients after the treatment.

The study of 183 patients with metastatic melanoma who died between 2009 and 2023 following immunotherapy treatment investigated sites of metastases at death in addition to settings and mechanisms of death.

“Notably, the associations identified between the sites of metastases and causes of death may inform management for patients with end-stage melanoma,” the study said.
READ THE ORIGINAL FULL ARTICLE